Auteurs
Analysis
Canada
Racine
Analysis
Canada
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Canada)

Index « Auteurs » - entrée « Valeria Buccheri »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Valer Dzupa < Valeria Buccheri < Valeria De Biasio  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000560 (2016) Sarit Assouline [Canada] ; Valeria Buccheri [Brésil] ; Alain Delmer [France] ; Gianluca Gaidano [Italie] ; Marek Trneny [République tchèque] ; Natalia Berthillon [Suisse] ; Michael Brewster [Royaume-Uni] ; Olivier Catalani [Suisse] ; Sai Li [Suisse] ; Christine Mcintyre [Royaume-Uni] ; Pakeeza Sayyed [Suisse] ; Xavier Badoux [Australie]Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial.
000866 (2015) Sarit Assouline [Canada] ; Valeria Buccheri [Brésil] ; Alain Delmer [France] ; Gianluca Gaidano [Italie] ; Christine Mcintyre [Royaume-Uni] ; Michael Brewster [Royaume-Uni] ; Olivier Catalani [Suisse] ; Florence Hourcade-Potelleret [Suisse] ; Pakeeza Sayyed [Suisse] ; Xavier Badoux [Australie]Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Administration, Intravenous
2Adult
2Aged
2Cyclophosphamide (administration & dosage)
2Female
2Humans
2Leukemia, Lymphocytic, Chronic, B-Cell (drug therapy)
2Male
2Middle Aged
2Rituximab (administration & dosage)
2Rituximab (adverse effects)
2Rituximab (pharmacokinetics)
2Vidarabine (administration & dosage)
2Vidarabine (analogs & derivatives)
1Administration, Cutaneous
1Antineoplastic Agents (administration & dosage)
1Antineoplastic Agents (adverse effects)
1Antineoplastic Agents (pharmacokinetics)
1Antineoplastic Agents, Alkylating (administration & dosage)
1Antineoplastic Agents, Alkylating (adverse effects)
1Antineoplastic Agents, Alkylating (pharmacokinetics)
1Antineoplastic Combined Chemotherapy Protocols
1Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Antineoplastic Combined Chemotherapy Protocols (pharmacokinetics)
1Cyclophosphamide (adverse effects)
1Cyclophosphamide (pharmacokinetics)
1Cyclophosphamide (therapeutic use)
1Drug Administration Schedule
1Injections, Subcutaneous
1Patient Preference
1Treatment Outcome
1Vidarabine (adverse effects)
1Vidarabine (pharmacokinetics)
1Vidarabine (therapeutic use)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Valeria Buccheri" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "Valeria Buccheri" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Valeria Buccheri
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024